Additionally, STAT-3 inhibits the proinflammatory effects of NF-κB signaling molecules, such as IL-12 in DCs, while it can also bind to NF-κB complexes to upregulate inflammatory genes, enhancing cancer progression [11,53]. The gene discussed is NFKB1; the disease is cancer.